Your session is about to expire
← Back to Search
Treatment for Lymphomatoid Papulosis
N/A
Recruiting
Led By Larisa Geskin, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Summary
This document is a protocol for a non-interventional human research study in which the investigator hopes to better understand the changes that take place in T cells in Cutaneous T-cell lymphoma (CTCL). The purpose of this study is to establish a protocol for the collection and storage of tissue samples from patients with CTCL for future research studies. Collection and storage of tissue samples from control patients will also be carried out.
Eligible Conditions
- Sézary Syndrome
- Lymphomatoid Papulosis
- Cutaneous T-Cell Lymphoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of biological specimen collections
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,471 Previous Clinical Trials
2,535,950 Total Patients Enrolled
Larisa Geskin, MDPrincipal Investigator - Columbia University
Morgan Stanley Children's Hospital, New York Presbyterian Hospital-Columbia Presbyterian Center, New York State Psychiatric Institute, NewYork-Presbyterian/Lawrence Hospital
A Einstein College Of Medical Of Yeshiva University (Medical School)
University Hlth Ctr Of Pittsburgh (Residency)
2 Previous Clinical Trials
218 Total Patients Enrolled
Larisa J. Geskin, MDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
70 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger